Meghalaya Sets New Benchmark in Public Healthcare System as the state pushes ahead with reforms, quality certification, and stronger public service delivery across districts. The phrase Meghalaya is central to this health story, and it captures...
India-US cooperation is rapidly becoming a key driver of innovation in biotech and healthcare, with both nations expanding partnerships in biotechnology, nuclear medicine, advanced research, and healthcare technology.
India plans national registry to track implantable medical devices and patients as the government moves to strengthen oversight in the healthcare sector and improve patient safety. The proposed system is expected to create a centralized databa...
Parexel has launched ParexelAI, a proprietary suite of human-led AI services and capabilities designed to improve speed, quality, and efficiency across the clinical development lifecycle for the life sciences industry.
Apollo HomeCare and Apollo AyurVAID have partnered to launch an integrated Transition Care service aimed at addressing the gap patients often face between hospital discharge and safely returning home.
Zydus Lifesciences is preparing for a major international expansion of its semaglutide business, with plans to roll out the drug across more than 20 markets over the next two years. The company is also betting on a sharp scale-up of its biosimil...
HAB Pharma targets Rs 3,000 crore revenue by 2030 as the pharmaceutical company moves ahead with an ambitious expansion strategy following its merger with Signature Phytochemical Industries. The deal marks a major step in HAB Pharma growth strateg...
Bayer is deepening its India self-care market push as the global pharmaceutical company bets on rising demand for preventive healthcare and over-the-counter wellness products to strengthen its position in one of its fastest-growing markets.
The Indian Patent Office has refused to grant US pharmaceutical firm AbbVie a Hepatitis C patent for its combination therapy glecaprevir/pibrentasvir, marketed globally as Mavyret.
Indian pharma firms post strong FY26 revenue growth as major companies across the pharmaceutical and healthcare sectors reported solid sales expansion, strong Q4 recoveries, and improving operational performance.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")